Covid vaccine volunteer dies in Brazil as a result of placebo injection



[ad_1]

Jakarta, CNN Indonesia –

A volunteer in Brazil who died on Wednesday (21/20) and then declared that he should not vaccine corona virusCOVID-19) except as a result of placebo injections.

According to local media reports cited AFP, Friday (10/23), stated that the volunteer was a 28-year-old doctor who handled patients with Covid-19. He participated in the clinical trial of the Covid-19 vaccine being developed by the University of Oxford.

Citing a source familiar with the pilot process, the Brazilian newspaper, Balloonand news agencies Bloomberg He said the doctor was in a control group and they injected him with a placebo, instead of having a vaccine test.


“After careful evaluation of this case in Brazil, there are no concerns about the safety of the clinical trial, and independent reviews other than the Brazilian regulator have recommended that the trial continue,” Oxford said in a statement.

The deceased was reportedly a young doctor who has treated Covid-19 patients since last March in the emergency room and intensive care unit of two Rio de Janeiro hospitals.

His family and friends said the doctor graduated from medical school last year and was in good health before contracting the coronavirus.

It is the first death reported in several coronavirus vaccine trials taking place around the world. However, the study administration said that an independent review had concluded that there were no safety concerns.

Trials of the vaccine developed with the pharmaceutical company AstraZeneca will continue.

AstraZeneca said medical confidentiality was unable to provide details on any individual volunteers, but that the independent review “does not raise any concerns about the continuation of the ongoing study.”

Brazil’s national health regulator Anvisa confirmed that it had been notified of the case on October 19.

The D’Or Research and Studies Institute (IDOR), which helps organize the trial in Brazil, said the independent review “raised no doubts about the safety of the study and recommended that it be continued.”

Previously, Oxford and AstraZeneca had to suspend vaccine testing in September when a volunteer in the UK experienced an unexplained illness.

The trials resumed after British regulators and independent reviews concluded that the disease was not a side effect of the vaccine.

IDOR said that half of the volunteers in the end-stage clinical trial that included a double-blind, randomized, controlled study had received a placebo. So far, around 8,000 volunteers have been vaccinated in Brazil and more than 20,000 around the world.

Study participants must be doctors, nurses, or other healthcare workers who are regularly exposed to the corona virus.

(years / a and p)

[Gambas:Video CNN]



[ad_2]